News and Updates

There was some really exciting T1D prevention research in day #3, and also screening for type 1 diabetes risk. Here is Jessica Dunne, Ph.D., senior director of the prevention portfolio, who gives a recap of day in T1D prevention research:

A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with type 1 diabetes maintain more consistent, and healthier, glucose levels. Two studies, shared this weekend, showed that the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology by Tandem® Diabetes Care resulted in more […]

There was some really amazing results out here in San Francisco! Here is Dan Finan, Ph.D., head of the Breakthrough T1D’s artificial pancreas and glucose control programs, to recap the day:

This is big. No, wait, this is ENORMOUSLY HUGE. Published today in the New England Journal of Medicine, an immune therapy demonstrated a significant delay in the time to onset of type 1 diabetes (T1D) in high-risk relatives of people with the disease. A significant delay meaning 2+ years! This is the first ever study […]

We’re at the 2019 American Diabetes Association Scientific Sessions, and there’s so much to learn! Here is the recap from Breakthrough T1D‘s assistant director for science, Andy Rakeman, Ph.D.:

The ADA’s Scientific Sessions has begun! Here, in the first recap, is Sanjoy Dutta, Ph.D., who highlights beta cell replacement therapies. Happy viewing!

The American Diabetes Association’s (ADA) 79th Scientific Sessions is almost here! From June 7-11, in San Francisco, CA, scientists and healthcare professionals will gather at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D researchers and Breakthrough T1D-funded scientists will also be there to hear first-hand and present new study results […]

On June 4, Breakthrough T1D’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee on Energy & Commerce, Health Subcommittee about Breakthrough T1D’s top legislative priority — securing a long-term renewal of the Special Diabetes Program (SDP) before it expires at the end of September. During the hearing, Dr. […]

The Breakthrough T1D Spring Beta Cell Replacement Consortium meeting, held recently in NYC, allowed 55 researchers from a diversity of destinations and expertise to exhibit beta cell replacement progress in a forum that encourages partnerships and real-time conversations. According to the rotating structure of the meeting, researchers who didn’t present at the meeting expounded upon […]

Hypoglycemia, or low blood sugar, can have serious effects, and it is, for most people with type 1 diabetes (T1D), the most feared complication of this disease. Even before it leads to a coma or seizures, hypoglycemia can carry with it sweatiness (like a panic attack), shaky hands, feeling weak and confusion. Typically, one would […]